0001209191-24-001779.txt : 20240117 0001209191-24-001779.hdr.sgml : 20240117 20240117171837 ACCESSION NUMBER: 0001209191-24-001779 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240112 FILED AS OF DATE: 20240117 DATE AS OF CHANGE: 20240117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Klassen Preston CENTRAL INDEX KEY: 0001493056 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35670 FILM NUMBER: 24539340 MAIL ADDRESS: STREET 1: 3344 N. TORREY PINES COURT, SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Regulus Therapeutics Inc. CENTRAL INDEX KEY: 0001505512 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 264738379 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4224 CAMPUS POINT COURT STREET 2: SUITE 210 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-202-6300 MAIL ADDRESS: STREET 1: 4224 CAMPUS POINT COURT STREET 2: SUITE 210 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2024-01-12 0 0001505512 Regulus Therapeutics Inc. RGLS 0001493056 Klassen Preston C/O REGULUS THERAPEUTICS INC. 4224 CAMPUS POINT CT., #210 SAN DIEGO CA 92121 1 1 0 0 President & Head of R & D 0 Stock Option (Right to Buy) 1.30 2024-01-12 4 A 0 120000 0.00 A 2034-01-11 Common Stock 120000 120000 D The stock option will vest ratably on a monthly basis over a 48 month period subject to the reporting person's continuous service to Regulus through each such vesting date. Christopher Aker, Attorney in Fact 2024-01-17